LOGOS CAPITAL
Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare. Based in San Francisco, Logos combines expertise across medical, scientific, and statistical disciplines to expand the depth of diligence in identifying compelling investment ideas and uncorrelated-market returns. They combine scientific diligence with their statistical modeling of clinical trials to achieve the highest levels of conviction in each position.
LOGOS CAPITAL
Industry:
Biotechnology Hedge Funds
Founded:
2019-01-01
Status:
Active
Contact:
+1 415 747 7342
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Similar Organizations
DTC Capital
DTC Capital is a Fundamentals-Focused Crypto Investment Fund.
Current Employees Featured
Graham Walmsley General Partner @ Logos Capital
General Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-13 | Elektrofi | Logos Capital investment in Series B - Elektrofi | 40 M USD |
| 2022-04-12 | Grain | Logos Capital investment in Series A - Grain | 16 M USD |
| 2022-04-06 | Triana Biomedicines | Logos Capital investment in Series A - Triana Biomedicines | 110 M USD |
| 2022-02-17 | Synthego | Logos Capital investment in Series E - Synthego | 200 M USD |
| 2022-02-15 | Parse Biosciences | Logos Capital investment in Series B - Parse Biosciences | 41.5 M USD |
| 2022-01-27 | Septerna | Logos Capital investment in Series A - Septerna | 100 M USD |
| 2022-01-27 | Simcha Therapeutics | Logos Capital investment in Series B - Simcha Therapeutics | 40 M USD |
| 2022-01-19 | Enliven Therapeutics | Logos Capital investment in Series B - Enliven Therapeutics | 85 M USD |
| 2021-12-07 | Freenome | Logos Capital investment in Series D - Freenome | 300 M USD |
| 2021-12-07 | Odyssey Therapeutics | Logos Capital investment in Series A - Odyssey Therapeutics | 218 M USD |
More informations about "Logos Capital"
Logos Capital
Logos Capital is dedicated to advancing healthcare through disciplined, data-driven investment in biotechnology. Our mission is to identify and fund life-changing therapeutics that will generate …See details»
Meet our team. - logoscapital.com
Logos Capital is led by a team of experts from diverse scientific and financial backgrounds, including chemistry, engineering, biology, and data science. We are committed to identifying …See details»
Logos Capital - Crunchbase Investor Profile
Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare. Based in San Francisco, Logos …See details»
Meet The Team - Logos Capital
Logos Capital is a team of over 20 people who also share this vision. At Logos Capital our mission is to help passionate and innovative founders disrupt the status quo. ... I am eager to connect with like-minded individuals and …See details»
Logos Capital
At Logos Capital, we bring more than just funding—we bring expertise. Our team of seasoned professionals, including experienced medical doctors, succesful business executives, and technology experts, is dedicated to identifying and …See details»
Logos Capital - Investments, Portfolio & Company Exits
Logos Capital 's most notable exits include Avidity Biosciences, Aligos Therapeutics, and Pliant Therapeutics. Which industries has this organization had the most exits in? Show . Avidity …See details»
Logos Capital - Innovations of the World
Eventually, Logos Capital helps them to manage and raise their own institutional investment fund(s). From the top-down, Logos works with partners in Multilateral Development Agencies, Foundations, Family Offices, Funds of Funds, …See details»
Logos Capital - F6S
Logos Capital is a fundamental biotechnology-focused investment partnership that combines scientific and financial expertise with in-house clinical trial analytics to identify transformative …See details»
Logos Capital - The Org
Logos Capital* is the global impact investment firm, with exposure to Venture Capital and Private Equity Funds focused to catalyze innovative solutions to society's most pressing problems. Logos Capital Mission: to drive global …See details»
Logos Capital investment portfolio - PitchBook
Logos Capital's latest investment was on 28-Jan-2025 in Helicore Biopharma, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
Logos Capital - Crunchbase Investor Profile
Logos Capital focuses on post-IPO equity investments in biotechnology and therapeutics, primarily within the health care and science sectors, with a geographical focus on San Francisco, California, United States. ... 6,127 …See details»
Logos Capital - Investor in San Francisco, California - Ask For …
Logos Capital is a fundamental biotechnology-focused investment partnership that combines scientific and financial expertise with in-house clinical trial analytics to identify transformative …See details»
Logos Capital | Institution Profile - Private Equity International
Logos Capital contact information Offices 1 Letterman Drive, Building C, Suite C3-350, San Francisco, 94129, United States Showing 1 of 1 Logos Capital officesSee details»
Logos Capital - teaserclub.com
Logos Capital is an equity hedge fund manager based in San Francisco, California, founded in March 2019. The firm specializes in fundamental biotechnology investments, leveraging both …See details»
Logos Capital - Gestora independente especializada em …
Jun 13, 2012 A LOGOS CAPITAL é uma gestora independente especializada em estratégias total return. Processo de investimento: • Estruturado para valorizar assimetrias. • Revisão …See details»
Logos Capital - Funding, Financials, Valuation & Investors
Sep 10, 2020 Logos Capital is a fundamental biotechnology-focused investment fund. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
Logos Capital – Medium
Miami, Nov 14, 2019 (Issuewire.com) — Logos Capital, a global impact investment firm, announced today that it has signed the Green Bond… May 22, 2020 Logos CapitalSee details»
Logos Capital - Crunchbase Investor Profile & Investments
Jan 9, 2025 Logos Capital is an investment firm. Private Equity Firm www.logoscapital.com.br ; 73,090; Highlights. Investments 2. Employee Profiles 2. Recent News & Activity. ... 9,954 …See details»
Capitals and MSE Foundation Announce Special 50th Anniversary …
Feb 25, 2025 The Capitals’ 50th Anniversary logo is also featured on the side of the hat in honor of the team’s historic season. In addition, the hat features the special 50th Anniversary red and …See details»
List of top Logos Capital Portfolio Companies - Crunchbase
Aug 13, 2015 Logos Capital is a fundamental biotechnology-focused investment fund. This list of organizations invested in by Logos Capital provides data on their funding history, investment …See details»